Neuroendocrine Carcinoma of Pancreas Clinical Trial
Official title:
Evaluation of Diagnostic Efficacy of Perfusion CT Using Wide Detector for Staging and Response Prediction After Chemotherapy in Pancreatic Cancer
The purpose of this study is
1. to determine whether the perfusion parameters in the normal pancreas and the pancreas
cancer (adenocarcinoma or neuroendocrine tumor) are different on perfusion CT
2. to determine whether initial perfusion parameters as well as perfusion parameter change
in pancreas adenocarcinoma before and after chemotherapy are different between
chemotherapy response group (CR, PR according to RECIST 1.1) and non response group (SD,
PD according to RECIST 1.1).
1. Performance of preoperative perfusion CT for preoperative staging is assessed by
comparing with operative finding and histologic disease staging
2. Estimation of initial or change of pancreas cancer perfusion parameters and whether
those can provide cut-off value for predicting response of chemotherapy in patients with
pancreas adenocarcinoma
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT03623984 -
Molecular-Guided Surgery for Pancreatic and GI Neuroendocrine Cancers
|
Early Phase 1 | |
| Recruiting |
NCT05641233 -
Preoperative Radiotherapy in Patients at High Risk of Postoperative Pancreatic Fistula After Pancreatoduodenectomy
|
Phase 1/Phase 2 |